Zoonotic infections are increasingly becoming public health menaces and are 
usually transmitted to humans due to unsuitable environmental conditions. One of 
them is hepatic capillariasis, caused by the parasite Capillaria hepatica, 
primarily a disease of rodents, with hepatic manifestations in humans. Although 
its prevalence is very low, it can cause significant morbidity and mortality, 
with cases reported from all over the world. The main infective form for humans 
is the embryonated egg of the parasite, which hatches in the intestine and 
ultimately colonize the liver. The larvae mature and reproduce, and eventually 
form embryonated eggs, which cause chronic focal inflammation and septal hepatic 
fibrosis. Clinical presentation mainly consists of fever, abdominal pain, 
hepatomegaly and eosinophilia. Spurious infection with unembryonated eggs cause 
gastrointestinal symptoms. Diagnostic modalities include liver biopsy, 
ultrasonography, CT scan, immunological tests like ELISA and IIFT. The infection 
can be treated mainly with a combination of benzimidazoles like thiabendazole, 
mebendazole and albendazole; with corticosteroids. The study emphasizes the need 
for hepatic capillariasis to be considered as a differential diagnosis in cases 
of suspected hepatitis, leptospirosis, abdominal lymphadenopathy or other 
hepatic or parasitic infections prevalent in the region concerned; and 
meticulously assess the cases to facilitate early diagnosis and prompt 
treatment, thus reducing the distress faced by patients.